Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001640334-24-001787
Filing Date
2024-11-26
Accepted
2024-11-26 13:01:52
Documents
89
Period of Report
2024-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K lxrp_10k.htm   iXBRL 10-K 1413849
2 EXECUTIVE EMPLOYMENT lxrp_ex109.htm EX-10.9 125789
3 EXECUTIVE EMPLOYMENT lxrp_ex1010.htm EX-10.10 99550
4 INSIDER TRADING lxrp_ex191.htm EX-19.1 42890
5 SUBSIDIARIES lxrp_ex211.htm EX-21.1 3406
6 CONSENT lxrp_ex231.htm EX-23.1 1692
7 CERTIFICATION lxrp_ex311.htm EX-31.1 9370
8 CERTIFICATION lxrp_ex312.htm EX-31.2 9602
9 CERTIFICATION lxrp_ex321.htm EX-32.1 6243
10 CERTIFICATION lxrp_ex322.htm EX-32.2 6259
11 CLAWBACK POLICY lxrp_ex971.htm EX-97.1 34112
17 lxrp_ex191img2.jpg GRAPHIC 15114
  Complete submission text file 0001640334-24-001787.txt   6597912

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20240831.xsd EX-101.SCH 71426
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20240831_lab.xml EX-101.LAB 346718
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20240831_cal.xml EX-101.CAL 50455
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20240831_pre.xml EX-101.PRE 284348
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20240831_def.xml EX-101.DEF 136946
92 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_10k_htm.xml XML 987566
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 001-39874 | Film No.: 241501251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)